Citations (13)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Fan Yang, Pengzhen Lei, Weihui Zeng, Jianwu Gao & Na Wu. (2020) RETRACTED ARTICLE: Long Noncoding RNA LINC00173 Promotes the Malignancy of Melanoma by Promoting the Expression of IRS4 Through Competitive Binding to microRNA-493. Cancer Management and Research 12, pages 3131-3144.
Read now
Read now
Luca Szalontay, Andrew V Schally, Petra Popovics, Irving Vidaurre, Awtar Krishan, Marta Zarandi, Ren-Zhi Cai, Anna Klukovits, Norman L Block & Ferenc G Rick. (2014) Novel GHRH antagonists suppress the growth of human malignant melanoma by restoring nuclear p27 function. Cell Cycle 13:17, pages 2790-2797.
Read now
Read now
Articles from other publishers (11)
Shengqiang Wang, Yi Wu, Yan Xu & Xianjun Tang. (2019) miR-10b promoted melanoma progression through Wnt/β-catenin pathway by repressing ITCH expression. Gene 710, pages 39-47.
Crossref
Crossref
Chun-Long Zhang, Yan-Jun Xu, Hai-Xiu Yang, Ying-Qi Xu, De-Si Shang, Tan Wu, Yun-Peng Zhang & Xia Li. (2017) sPAGM: inferring subpathway activity by integrating gene and miRNA expression-robust functional signature identification for melanoma prognoses. Scientific Reports 7:1.
Crossref
Crossref
Kaushala Jayawardana, Sarah-Jane Schramm, Varsha Tembe, Samuel Mueller, John F. Thompson, Richard A. Scolyer, Graham J. Mann & Jean Yang. (2016) Identification, Review, and Systematic Cross-Validation of microRNA Prognostic Signatures in Metastatic Melanoma. Journal of Investigative Dermatology 136:1, pages 245-254.
Crossref
Crossref
Sarah L. Miles, Adam P. Fischer, Sandeep J. Joshi & Richard M. Niles. (2015) Ascorbic acid and ascorbate-2-phosphate decrease HIF activity and malignant properties of human melanoma cells. BMC Cancer 15:1.
Crossref
Crossref
Kaushala Jayawardana, Sarah-Jane Schramm, Lauren Haydu, John F. Thompson, Richard A. Scolyer, Graham J. Mann, Samuel M?ller & Jean Yee Hwa Yang. (2015) Determination of prognosis in metastatic melanoma through integration of clinico-pathologic, mutation, mRNA, microRNA, and protein information. International Journal of Cancer 136:4, pages 863-874.
Crossref
Crossref
Michele Ceolin Foletto & Sandra Elisa Haas. (2014) Cutaneous melanoma: new advances in treatment. Anais Brasileiros de Dermatologia 89:2, pages 301-310.
Crossref
Crossref
Sehar Afreen & Said Dermime. (2014) The immunoinhibitory B7-H1 molecule as a potential target in cancer: Killing many birds with one stone. Hematology/Oncology and Stem Cell Therapy 7:1, pages 1-17.
Crossref
Crossref
Fatemeh Teimouri, Shekoufeh Nikfar & Mohammad Abdollahi. (2013) Efficacy and side effects of dacarbazine in comparison with temozolomide in the treatment of malignant melanoma. Melanoma Research 23:5, pages 381-389.
Crossref
Crossref
Jazlyn Read. (2013) Recent advances in cutaneous melanoma: towards a molecular model and targeted treatment. Australasian Journal of Dermatology 54:3, pages 163-172.
Crossref
Crossref
Ricardo Vieira, Maria José Simões, Susana Carmona, Conceição Egas, Carlos Faro & Américo Figueiredo. (2013) Identification of DLEC1 D215N Somatic Mutation in Formalin Fixed Paraffin Embedded Melanoma and Melanocytic Nevi Specimens. Journal of Skin Cancer 2013, pages 1-4.
Crossref
Crossref
Azim Hossain, Faisal F. Y. Radwan, Bently P. Doonan, Jason M. God, Lixia Zhang, P. Darwin Bell & Azizul Haque. (2012) A possible cross-talk between autophagy and apoptosis in generating an immune response in melanoma. Apoptosis 17:10, pages 1066-1078.
Crossref
Crossref